Orient Pharma Co., Ltd. (TPEX:4166)
Taiwan · Delayed Price · Currency is TWD 24.35
+0.15 (0.62%)
Mar 5, 2026, 1:30 PM CST
Orient Pharma Market Cap
Orient Pharma has a market cap or net worth of 5.92 billion as of March 5, 2026. Its market cap has decreased by -29.24% in one year.
Market Cap
5.92B
Enterprise Value
5.57B
Revenue
1.28B
Ranking
n/a
PE Ratio
42.88
Stock Price
24.35
Market Cap Chart
Since June 15, 2012, Orient Pharma's market cap has increased from 4.12B to 5.92B, an increase of 43.78%. That is a compound annual growth rate of 2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 5.94B | -6.50% |
| Dec 31, 2025 | 6.36B | -20.85% |
| Dec 31, 2024 | 8.03B | 80.00% |
| Dec 29, 2023 | 4.46B | 14.13% |
| Dec 30, 2022 | 3.91B | 11.76% |
| Dec 30, 2021 | 3.50B | 28.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foresee Pharmaceuticals | 12.63B |
| Handa Pharmaceuticals | 12.51B |
| Standard Chemical & Pharmaceutical | 11.44B |
| Alar Pharmaceuticals | 11.16B |
| Formosa Laboratories | 6.31B |
| SCI Pharmtech | 5.96B |
| Orient EuroPharma | 3.80B |
| Easywell Biomedicals | 3.52B |